Results 121 to 130 of about 2,419 (196)

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain. [PDF]

Int J Chron Obstruct Pulmon Dis, 2022
Trigueros JA, Garin N, Baloira A, Aceituno S, Calvo A, Prades M, Touron C, Martínez A, Torres C.   +8 more
europepmc   +1 more source

Response to: Letter to the Editor Regarding 'Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study'. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +4 more
europepmc   +1 more source

Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation. [PDF]

Respir Res, 2022
Suraya R, Nagano T, Ryanto GRT, Effendi WI, Hazama D, Katsurada N, Yamamoto M, Tachihara M, Emoto N, Nishimura Y, Kobayashi K.   +10 more
europepmc   +1 more source

Efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in patients with tuberculosis-associated chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. [PDF]

J Thorac Dis
Wu F, Huang S, Lei M, Deng Z, Wan Q, Tang G, Zhou K, Liang X, Abduwaiti T, Turgon R, Zhang K, Turgon K, Li Y, Li H, Zou W.   +14 more
europepmc   +1 more source

Budesonide/Formoterol Fumarate Dihydrate Inhalation Aerosol [PDF]

, 2020
openaire   +1 more source

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study. [PDF]

J Aerosol Med Pulm Drug Deliv, 2022
Usmani OS, Baldi S, Warren S, Panni I, Girardello L, Rony F, Taylor G, DeBacker W, Georges G.   +8 more
europepmc   +1 more source

Beclomethasone Dipropionate/Formoterol Fumarate Inhalation Solution [PDF]

, 2020
openaire   +1 more source

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study. [PDF]

Adv Ther
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J, ORESTES group.   +5 more
europepmc   +1 more source

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study. [PDF]

Pulm Ther
Figueira-Gonçalves JM, Alcázar-Navarrete B, Casitas-Mateo R, González J, Gotera-Rivera CM, Herrejón-Silvestre A, Margallo-Iribarnegaray J, Martín-Lana M, Pallarés-Sanmartín A, Pascual-Guardia S, Saura-Vinuesa A, Corregidor-García C, Fitas E, Sánchez-Covisa J.   +13 more
europepmc   +1 more source

Observation of Budesonide and Formoterol Fumarate Powder for Inhalation in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

, 2011
目的:观察布地奈德福莫特罗粉吸入剂治疗慢性阻塞性肺疾病急性加重期(AECOPd)的临床疗效和安全性。方法:80例AECOPd患者随机分为观察组和对照组各40例,两组均采用常规治疗,观察组加用布地奈德福莫特罗粉吸入剂,比较两组临床疗效、症状明显缓解时间、不良反应。结果:观察组总有效率95.0%,对照组总有效率80.0%,观察组疗效优于对照组 ...
杨丽雄, 蔡丽秋
core